Artwork

Content provided by Open to Debate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Open to Debate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Prescription Weight Loss Drugs for All?

53:15
 
Distribuie
 

Manage episode 462927311 series 2300998
Content provided by Open to Debate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Open to Debate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have opened doors for people to lose weight. Should everyone have the option to take it? Those arguing “yes” say obesity needs to be treated using every available tool, especially for people for whom diet, lifestyle changes, and exercise aren’t enough. Those arguing “no” are concerned about its side effects and the risks if people don’t take them as directed. Now we debate: should prescription weight loss drugs be available for all?

Arguing Yes: David Allison, Obesity Researcher; Dean and Distinguished Professor at the Indiana University School of Public Health-Bloomington

Arguing No: Stuart W. Flint, Associate Professor of the Psychology of Obesity at the University of Leeds

Emmy award-winning journalist John Donvan moderates

Learn more about your ad choices. Visit podcastchoices.com/adchoices

  continue reading

391 episoade

Artwork

Prescription Weight Loss Drugs for All?

Open to Debate

12,159 subscribers

published

iconDistribuie
 
Manage episode 462927311 series 2300998
Content provided by Open to Debate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Open to Debate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have opened doors for people to lose weight. Should everyone have the option to take it? Those arguing “yes” say obesity needs to be treated using every available tool, especially for people for whom diet, lifestyle changes, and exercise aren’t enough. Those arguing “no” are concerned about its side effects and the risks if people don’t take them as directed. Now we debate: should prescription weight loss drugs be available for all?

Arguing Yes: David Allison, Obesity Researcher; Dean and Distinguished Professor at the Indiana University School of Public Health-Bloomington

Arguing No: Stuart W. Flint, Associate Professor of the Psychology of Obesity at the University of Leeds

Emmy award-winning journalist John Donvan moderates

Learn more about your ad choices. Visit podcastchoices.com/adchoices

  continue reading

391 episoade

Toate episoadele

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință

Listen to this show while you explore
Play